Nantahala Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-110,017
| Closed | -$9.19M | – | 117 |
|
|
2023
Q4 | $9.19M | Sell |
110,017
-69,240
| -39% | -$5.78M | 0.55% | 33 |
|
|
2023
Q3 | $5.28M | Hold |
179,257
| – | – | 0.45% | 43 |
|
|
2023
Q2 | $5.85M | Buy |
179,257
+149,257
| +498% | +$4.87M | 0.57% | 38 |
|
|
2023
Q1 | $1.06M | Buy |
30,000
+25,198
| +525% | +$887K | 0.08% | 82 |
|
|
2022
Q4 | $220K | Buy |
+4,802
| New | +$220K | 0.01% | 95 |
|